glp 1 without diabetes Researchers find GLP-1 medications safe to continue before surgery in patients with and obesity GLP-1 use tripled among non-diabetics,

Not quite

One year after stopping semaglutide 2.4 mg, participants regained two-thirds of their prior weight loss

The gold standard treatments are dopamine replacement with dopaminergic medications or brain stimulation

CNN recently reported on the growing scientific and regulatory attention being directed at ibogaine research, particularly in areas related to opioid addiction and treatment-resistant mental health conditions

Looking ahead, the key strategies for product innovation and differentiation are likely to focus on five main directions: expanding the therapeutic indications, achieving precision treatment with multiple biological targets, optimizing the clinical application of drug combinations, developing new formulations of oral medications, and extending the duration of drug action